Ascendis Health: Director's associate acquires shares in on-market transactions

ACN Capital (Pty) Ltd, associated with director Carl Neethling, executed on-market purchases of Ascendis Health Limited shares on April 8 and 9, 2025, acquiring 115,127 and 522,276 shares, respectively, at a price of ZAR80.00 per share. These transactions amounted to ZAR92,101.60 and ZAR417,820.80, respectively. Neethling, as the ultimate controlling shareholder of ACN Capital (Pty) Ltd, holds an indirect, beneficial interest in these shares. Similarly, Calibre Investment Holdings (Pty) Ltd, associated with director Theunis de Bruyn acquired 115,127 and 522,276 shares at a price of ZAR80.00, for a total of ZAR92,101.60 and ZAR417,820.80 respectively on April 8 and 9, 2025. As director and shareholder, de Bruyn has indirect beneficial interest. The purchases, made by entities linked to key company directors, indicate a potentially positive outlook on Ascendis Health's prospects. Clearance was obtained for these dealings in compliance with JSE Limited Listings Requirements.